InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
30%
T+90 mean return
-7.4%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Zovighian Bernard J, Chief Executive Officer. Director active across 1 company, notably Edwards Lifesciences Corp. Cumulatively, 25 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €4m. History available since 3 May 2022. The latest transaction was filed on 11 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations25 total
47,207 shares0Common StockSEC:0001225208-26-005172:0
515 shares@ US$83.980.0001% mcap1.9% of flowCommon StockSEC:0001225208-26-004968:0
25,350 shares@ US$59.2567Common StockSEC:0001225208-26-001893:0
25,350 shares@ US$59.256719.0% of flowCommon StockSEC:0001225208-25-009840:0
16,099 shares@ US$77.213819.8% of flowCommon StockSEC:0001225208-25-005684:0
5,815.551 shares0Common StockSEC:0001225208-25-005233:0
2,860 shares@ US$73.684.2% of flowCommon StockSEC:0001225208-25-005052:0
4,253 shares@ US$74.926.3% of flowCommon StockSEC:0001225208-25-004941:0
527 shares@ US$75.650.8% of flowCommon StockSEC:0001225208-25-004799:0
7,463 shares@ US$45.27677.0% of flowCommon StockSEC:0001225208-25-003195:0
8,617 shares@ US$87.6815.6% of flowCommon StockSEC:0001225208-24-006448:0
2,854 shares@ US$86.725.1% of flowCommon StockSEC:0001225208-24-005979:0
33,500 shares0Common StockSEC:0001225208-24-005886:0
527 shares@ US$85.060.9% of flowCommon StockSEC:0001225208-24-005743:0
2,558.621 shares@ US$83.53894.4% of flowCommon StockSEC:0001225208-23-007850:0
22,525 shares0Common StockSEC:0001225208-23-005916:0
5,003 shares0Common StockSEC:0001225208-23-005622:0
359 shares@ US$87.810.6% of flowCommon StockSEC:0001225208-23-005437:0
4,811 shares@ US$103.6610.9% of flowCommon StockSEC:0001225208-22-009330:0
4,809 shares@ US$87.750.0008% mcap20.5% of flowCommon StockSEC:0001225208-22-008104:0
9,000 shares@ US$100.83210.0017% mcap43.0% of flowCommon StockSEC:0001225208-22-007468:0
4,809 shares@ US$95.520.0009% mcap21.7% of flowCommon StockSEC:0001225208-22-007372:0
1,711 shares@ US$95.930.0003% mcap7.9% of flowCommon StockSEC:0001225208-22-007140:0
633 shares@ US$100.520.0001% mcap3.1% of flowCommon StockSEC:0001225208-22-006819:0
4,150 shares0Common StockSEC:0001225208-22-006585:0
25 of 25 declarations
About Zovighian Bernard J
Bernard J. Zovighian is the CEO at Edwards Lifesciences Corp. He leads the company's operations and development strategies, ensuring its growth and profitability. His experience in the medical sector enables him to navigate effectively in a complex environment.
